TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT05132413 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04167969 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06515652 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT06515652 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06515652 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT05890014 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05609747 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05924841 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study NCT04859894 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT06461689 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06460454 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT04283435 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study NCT04283435 — Pharmacodynamic Biomarker (PDY): Cyclic guanosine monophosphate
Study NCT05730283 — Predictive Biomarker (PRD): NTM mRNA
Genes: NTM; IGLON2; NT; UNQ297/PRO337
Study NCT05489107 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06455826 — Predictive Biomarker (PRD): PRPF31 mRNA
Genes: PRPF31; PRP31
Study NCT05544552 — Predictive Biomarker (PRD): FGFR3 mRNA
Genes: FGFR3; JTK4
Study NCT05774899 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT05774899 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05774899 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04514471 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06189378 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05413057 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06295081 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study NCT05432375 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT06026319 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04865107 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT06180161 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT05553314 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study NCT04642352 — Predictive Biomarker (PRD): SLN mRNA
Genes: SLN
Study NCT05636644 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05668975 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT06332820 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT02365974 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05721443 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05721443 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT05335629 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT04335032 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05103969 — Predictive Biomarker (PRD): POLE mRNA
Genes: POLE; POLE1
Study NCT05103969 — Predictive Biomarker (PRD): POLD1 mRNA
Genes: POLD1; POLD
Study NCT05468710 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT05468710 — Safety Biomarker (SAF): Platelet to lymphocyte
Study NCT05660226 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00002252 — Predictive Biomarker (PRD): SMS mRNA
Genes: SMS
Study NCT06109558 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05369416 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05658913 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT05823532 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05823532 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05049616 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT05049616 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06036823 — Surrogate Endpoint (SUR): Serum potassium
Study NCT05886114 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06099093 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06557707 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT05828849 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05692895 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT04658433 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT04658433 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT04658433 — Predictive Biomarker (PRD): TMPRSS2 mRNA
Genes: TMPRSS2; PRSS10
Study NCT05962437 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): FKBP5 mRNA
Genes: FKBP5; AIG6; FKBP51
Study NCT05373277 — Predictive Biomarker (PRD); Safety Biomarker (SAF): ABCG2
Genes: EST157481; MXR; BCRP; ABCP; CD338
Study NCT00000882 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04920344 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06121960 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study NCT05342857 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00001067 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02587884 — Predictive Biomarker (PRD): ASPH mRNA
Genes: ASPH; BAH
Study NCT06098092 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05212584 — Predictive Biomarker (PRD): CD7 mRNA
Genes: CD7
Study NCT05341050 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT05341050 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT04940182 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05480722 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06288282 — Predictive Biomarker (PRD): BPI mRNA
Genes: BPI
Study NCT06429488 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT02624570 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT00965315 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT06411522 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06548503 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT04998214 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT06340165 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05747430 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06105814 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study NCT06250777 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05394233 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05847855 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT04471779 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT06324812 — Safety Biomarker (SAF): IL4
Genes: BSF1; IL-4; BCGF1; BCGF-1; MGC79402
Study NCT04316390 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT06467968 — Predictive Biomarker (PRD): SSTR2 mRNA
Genes: SSTR2
Study NCT04934527 — Predictive Biomarker (PRD): FCGR3B
Genes: CD16; CD16b; FcgammaRIIIb; FcRIIIb
Study NCT05798143 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT05798143 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06261918 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04835480 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT05236413 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05822193 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05568823 — Predictive Biomarker (PRD): ELK1 mRNA
Genes: ELK1
Study NCT06125561 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT04784039 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT06469593 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04803539 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05498597 — Predictive Biomarker (PRD): Folate receptor alpha
Genes: FOLR1; FOLR
Study NCT05693753 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT06341101 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT06341101 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06378580 — Predictive Biomarker (PRD): FGFR1 mRNA
Genes: FGFR1; BFGFR; CEK; FGFBR; FLG; FLT2; HBGFR
Study NCT06378580 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT06378580 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT06378580 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study NCT04668339 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04668339 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05690061 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05690061 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05139420 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT05761145 — Predictive Biomarker (PRD): CPT1A mRNA
Genes: CPT1A; CPT1
Study NCT05761145 — Predictive Biomarker (PRD): HOXC9 mRNA
Genes: HOXC9; HOX3B
Study NCT06189690 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT06189690 — Safety Biomarker (SAF): BDNF
Study NCT06431984 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study NCT05039073 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT04857619 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00172445 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study NCT05952817 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT05361278 — Surrogate Endpoint (SUR): Bacterial count
Study NCT05180162 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT04526860 — Predictive Biomarker (PRD): LEP mRNA
Genes: LEP; OB; OBS
Study NCT04868448 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05321706 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05580159 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05838066 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05942079 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study NCT05837585 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05061147 — Predictive Biomarker (PRD): MAX mRNA
Genes: MAX; BHLHD4
Study NCT00210340 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT04062721 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT06549192 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05889871 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05889871 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05502952 — Pharmacodynamic Biomarker (PDY): Cyclic adenosine monophosphate
Study NCT05502952 — Pharmacodynamic Biomarker (PDY): Cyclic guanosine monophosphate
Study NCT06558305 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study NCT06558305 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04840004 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04840004 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT04840004 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT04840004 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT04840004 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT05815069 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT05905848 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT05952869 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05197257 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05149781 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05292274 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05717179 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00043706 — Safety Biomarker (SAF): Transforming growth factor beta 1
Genes: TGFB1; TGFB
Study NCT06167629 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06161922 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05737589 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT04712864 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05680077 — Predictive Biomarker (PRD): KCNA3 mRNA
Genes: KCNA3; HGK5
Study NCT05680077 — Predictive Biomarker (PRD): OTOP2 mRNA
Genes: OTOP2
Study NCT05146310 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT00002387 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05572645 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05791188 — Surrogate Endpoint (SUR): Serum sodium
Study NCT05791188 — Surrogate Endpoint (SUR): Serum potassium
Study NCT05791188 — Surrogate Endpoint (SUR): Serum calcium
Study NCT04843020 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT06429332 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04939116 — Predictive Biomarker (PRD): ANG mRNA
Genes: ANG; RNASE5
Study NCT05610683 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05610683 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05943314 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study NCT05436093 — Predictive Biomarker (PRD): CLDN18 mRNA
Genes: CLDN18; UNQ778/PRO1572
Study NCT05271474 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study NCT04729374 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05627323 — Predictive Biomarker (PRD): MMP2 mRNA
Genes: MMP2; CLG4A
Study NCT05925790 — Safety Biomarker (SAF): Interleukin 1
Study NCT05925790 — Monitoring Biomarker (MOI): Urokinase plasminogen activator surface receptor
Genes: PLAUR; MO3; UPAR
Study NCT04894448 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06535386 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT06442644 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06330662 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05546502 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06547099 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT06303206 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05744115 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05901428 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05901428 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT05901428 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05701605 — Pharmacodynamic Biomarker (PDY): Human leukocyte antigen DR
Study NCT06066814 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT06069323 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT05973474 — Predictive Biomarker (PRD): AIP mRNA
Genes: AIP; XAP2
Study NCT05540457 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06263920 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05341973 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06369831 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06369831 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05106517 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06194630 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT05848986 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT04039204 — Predictive Biomarker (PRD): BCL6 mRNA
Genes: BCL6; BCL5; LAZ3; ZBTB27; ZNF51
Study NCT06385951 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT05435352 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT05810870 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT05810870 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT05810870 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05840510 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT05209425 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05209425 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study NCT06342752 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Mucin-1
Genes: MUC1; PUM
Study NCT05202704 — Pharmacodynamic Biomarker (PDY): Heat pain threshold
Study NCT04411758 — Monitoring Biomarker (MOI): Heme oxygenase 1
Genes: HMOX1; HO; HO1
Study NCT04411758 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04411758 — Safety Biomarker (SAF): Interleukin 1
Study NCT04411758 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04411758 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05445128 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT05637866 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05227183 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05227183 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT05227183 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT05227183 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Interleukin 13
Genes: IL13; NC30
Study NCT05227183 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06609291 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT05608759 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT04714619 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04714619 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04714619 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05625256 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04474938 — Surrogate Endpoint (SUR): Hematologic response
Study NCT05027815 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06208345 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06208345 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT05882942 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05259514 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06159062 — Monitoring Biomarker (MOI): HBV DNA
Study NCT06556862 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06556862 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06556862 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT06445296 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04858633 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study NCT05845736 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06328101 — Predictive Biomarker (PRD): AIP mRNA
Genes: AIP; XAP2
Study NCT04922970 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05015608 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT05015608 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05695352 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05253638 — Predictive Biomarker (PRD): MIF mRNA
Genes: MIF; GLIF; MMIF
Study NCT04727528 — Surrogate Endpoint (SUR): Serum potassium
Study NCT05200832 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05739188 — Predictive Biomarker (PRD): GPRC5D mRNA
Genes: GPRC5D
Study NCT06120296 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05154396 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06495983 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04914052 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05626023 — Predictive Biomarker (PRD): TH mRNA
Genes: TH; TYH
Study NCT05409326 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05101174 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT05101174 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT05101174 — Safety Biomarker (SAF): BDNF
Study NCT05567380 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05567380 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study NCT05567380 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT05567380 — Predictive Biomarker (PRD): JAK1
Genes: JAK1A; JTK3